1. Home
  2. ALT vs MTW Comparison

ALT vs MTW Comparison

Compare ALT & MTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • MTW
  • Stock Information
  • Founded
  • ALT 1997
  • MTW 1902
  • Country
  • ALT United States
  • MTW United States
  • Employees
  • ALT N/A
  • MTW N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • MTW Construction/Ag Equipment/Trucks
  • Sector
  • ALT Health Care
  • MTW Industrials
  • Exchange
  • ALT Nasdaq
  • MTW Nasdaq
  • Market Cap
  • ALT 292.0M
  • MTW 358.5M
  • IPO Year
  • ALT N/A
  • MTW N/A
  • Fundamental
  • Price
  • ALT $3.83
  • MTW $9.89
  • Analyst Decision
  • ALT Strong Buy
  • MTW Hold
  • Analyst Count
  • ALT 6
  • MTW 4
  • Target Price
  • ALT $17.40
  • MTW $11.00
  • AVG Volume (30 Days)
  • ALT 3.0M
  • MTW 381.2K
  • Earning Date
  • ALT 08-12-2025
  • MTW 08-07-2025
  • Dividend Yield
  • ALT N/A
  • MTW N/A
  • EPS Growth
  • ALT N/A
  • MTW 436.41
  • EPS
  • ALT N/A
  • MTW 1.26
  • Revenue
  • ALT $20,000.00
  • MTW $2,131,200,000.00
  • Revenue This Year
  • ALT N/A
  • MTW N/A
  • Revenue Next Year
  • ALT $761,880.20
  • MTW $4.66
  • P/E Ratio
  • ALT N/A
  • MTW $7.86
  • Revenue Growth
  • ALT N/A
  • MTW N/A
  • 52 Week Low
  • ALT $2.90
  • MTW $7.06
  • 52 Week High
  • ALT $11.16
  • MTW $13.62
  • Technical
  • Relative Strength Index (RSI)
  • ALT 51.79
  • MTW 38.48
  • Support Level
  • ALT $3.35
  • MTW $9.91
  • Resistance Level
  • ALT $3.66
  • MTW $10.19
  • Average True Range (ATR)
  • ALT 0.19
  • MTW 0.35
  • MACD
  • ALT 0.07
  • MTW 0.08
  • Stochastic Oscillator
  • ALT 86.18
  • MTW 61.07

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About MTW Manitowoc Company Inc. (The)

Manitowoc Co Inc provides engineered lifting solutions. It designs and manufactures mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks. It offers products under brand names such as Grove, Manitowoc, National Crane, Potain, Shuttlelift, and Manitowoc Crane Care. Its crane products serve dealers, rental companies, contractors, and government entities in diverse markets, including energy production/distribution and utility, petrochemical and industrial, infrastructure, and commercial/residential construction. Manitowoc has three reportable segments: the Americas, Europe and Africa, and the Middle East and Asia-Pacific. The Americas segment generates the majority of the revenue for the company.

Share on Social Networks: